Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.
about
Hepatitis B: future curative strategiesTreatment of rheumatic diseases and hepatitis B virus coinfectionImportin β Can Bind Hepatitis B Virus Core Protein and Empty Core-Like Particles and Induce Structural ChangesRelationship between TNF-<alpha> gene promoter polymorphisms and outcomes of hepatitis B virus infections: a meta-analysis.Inhibition of hepatitis B virus replication by the host zinc finger antiviral protein.Hepatitis B virus core protein sensitizes hepatocytes to tumor necrosis factor-induced apoptosis by suppression of the phosphorylation of mitogen-activated protein kinase kinase 7The inhibitory effect of the hepatitis B virus singly-spliced RNA-encoded p21.5 protein on HBV nucleocapsid formation.Inhibition of hepatitis B virus replication by cIAP2 involves accelerating the ubiquitin-proteasome-mediated destruction of polymerase.Hepatocyte nuclear factor 1α downregulates HBV gene expression and replication by activating the NF-κB signaling pathwayHepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigenHepatitis B virus replication and release are independent of core lysine ubiquitinationHBV replication is significantly reduced by IL-6.Circulating cytokines and histological liver damage in chronic hepatitis B infection.The role of tumour necrosis factor in hepatitis B infection: Jekyll and Hyde.Association of TNF-α Gene Polymorphisms with Production of Protein and Susceptibility to Chronic Hepatitis B Infection in the South East Iranian Population.Adenoviral delivery of recombinant hepatitis B virus expressing foreign antigenic epitopes for immunotherapy of persistent viral infection.Enhancing the antihepatitis B virus immune response by adefovir dipivoxil and entecavir therapies.Management of rheumatic disease with comorbid HBV or HCV infection.The TNF-α -308 Promoter Gene Polymorphism and Chronic HBV Infection.The immune tolerant phase of chronic HBV infection: new perspectives on an old conceptAge-Dependent Immune Events during HBV Infection from Birth to Adulthood: An Alternative Interpretation.New paradigms in hepatitis B management: only diamonds are forever.Prospects and progress of DNA vaccines for treating hepatitis B.Functions of invariant NK T cells are modulated by TLR ligands and IFN-α.The C-terminal region of the hepatitis B virus X protein is essential for its stability and function.Hepatitis B virus HBx protein localizes to mitochondria in primary rat hepatocytes and modulates mitochondrial membrane potential.Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.Can engineered "designer" T cells outsmart chronic hepatitis B?Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment.Reactivation of hepatitis B virus infection following ruxolitinib treatment in a patient with myelofibrosis.Tumor necrosis factor: The key to hepatitis B viral clearance.Immunotherapy for Chronic Hepatitis B Virus Infection.Intracellular interleukin-32γ mediates antiviral activity of cytokines against hepatitis B virus
P2860
Q27011623-CFC391CE-49EF-4F9C-B37D-B2FAA5A82D53Q28084305-CEE0640C-E84B-4740-B88C-8C5FF39D1C20Q28553490-71B7BC2D-F2CC-48CD-9055-C5063565D776Q33900208-8D3DC9B6-C617-4786-A591-E405B3C6BB99Q34819738-3268286F-DB47-4417-9ED5-E5CEF80E2A49Q35115529-46CD53C8-17A2-49CF-B20B-547009461F6AQ35191793-C93AFDD8-1D1E-45B8-8657-BF5F3E70C0B0Q35362817-B2E801AA-CC28-4235-8C00-0D26731FE1AFQ36314644-79770059-F020-4015-9C12-E4F3CAB18669Q36845647-67489692-F3F6-4011-8FB1-67F625C5026FQ37192164-683038C6-F972-48BD-B349-C0185478764DQ37204748-A9F95660-44D8-462B-95A1-EE92358E86A4Q37323553-6686E673-5297-4DD3-A51F-9C13DCC60D02Q37538505-ED2E9F9E-0B84-462E-B071-8127F388D89AQ37547187-3500F04D-FE44-492B-B7FF-BD485D86DC7BQ37644059-CE90D6C3-0385-40DB-B4DF-C1AFBB1CF78FQ37729239-6FFF4DBA-3344-4124-A499-9D045AFCF4E7Q38008173-150E7586-A0F2-43AF-B5EB-126A3DBE1B0CQ38058328-439798CC-273C-406E-B6CC-65DF7BAC7FEFQ38245181-4F11CD57-3A2A-41CA-9B74-64B959396A22Q38258081-A578BACF-5922-47F4-B279-3388C1E6B4AAQ38588187-BC3E719D-4E7C-49CC-9A7F-97662C24DD3EQ38664504-7019F660-1A18-46CC-800D-1B24B463D2EBQ38984210-5495EA12-9982-4949-A4EB-ABD041524E98Q39640953-5DE93406-D776-4098-9EEE-A7612FB74F91Q39764218-F09C5E40-46F3-46DD-B046-A7AEDB1E1E93Q40809408-42429C31-84AE-4DE5-A17A-FFD18AE2B9EFQ41218683-DFFB85A4-F05C-4F20-A2A8-F412480C56E3Q42243264-B2CF4035-F2BF-4752-AD0A-93AE4DDCF508Q45350105-CC283900-4758-404E-8EDC-A80E711C2DBAQ47548536-4C0E4A0F-A038-4206-958F-3382C49B66E6Q47556416-96B1F930-C51C-4BE3-966C-E5D8EA29433CQ58774481-B973900C-6F99-4DCD-A743-501DDDF54DEC
P2860
Tumor necrosis factor activates a conserved innate antiviral response to hepatitis B virus that destabilizes nucleocapsids and reduces nuclear viral DNA.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumor necrosis factor activate ...... and reduces nuclear viral DNA.
@ast
Tumor necrosis factor activate ...... and reduces nuclear viral DNA.
@en
type
label
Tumor necrosis factor activate ...... and reduces nuclear viral DNA.
@ast
Tumor necrosis factor activate ...... and reduces nuclear viral DNA.
@en
prefLabel
Tumor necrosis factor activate ...... and reduces nuclear viral DNA.
@ast
Tumor necrosis factor activate ...... and reduces nuclear viral DNA.
@en
P2860
P356
P1433
P1476
Tumor necrosis factor activate ...... and reduces nuclear viral DNA.
@en
P2093
Robyn Puro
P2860
P304
P356
10.1128/JVI.00554-07
P407
P577
2007-05-02T00:00:00Z